The spatial folding of chromosomes inside the nucleus has regulatory effects on gene expression, yet the impact of genome reshuffling on this organization remains unclear. Here, we take advantage of chromosome conformation capture in combination with single-nucleotide polymorphism (SNP) genotyping and analysis of crossover events to study how the higher-order chromatin organization and recombination landscapes are affected by chromosomal fusions in the mammalian germ line.
We demonstrate that chromosomal fusions alter the nuclear architecture during meiosis, including an increased rate of heterologous interactions in primary spermatocytes, and alterations in both chromosome synapsis and axis length.
These disturbances in topology were associated with changes in genomic landscapes of recombination, resulting in detectable genomic footprints. Overall, we show that chromosomal fusions impact the dynamic genome topology of germ cells in two ways: (i) altering chromosomal nuclear occupancy and synapsis, and (ii) reshaping landscapes of recombination.
Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of HNSCC with or without HPV infection
Head and neck squamous cell carcinoma (HNSCC) are the sixth most common cancer type in the world. Human papillomavirus (HPV) infection is an emerging risk factor for HNSCC. Immune infiltration of HNSCC is linked to therapeutic results. This article aimed to decide whether variations in HPV status affect immune infiltration, molecular mechanism, and how these results vary in HNSCC patients.
We investigated the tumor-infiltrating immune cells (TIICs) and immune-related gene differences between HPV (+) and HPV (-) HNSCC. The gene expression quantification data of HNSCC and their clinical information were download from the TCGA database. Immune-related genes have been linked to the ImmPort platform.
After analyzed of 22 TIICs in the HNSCC tumor environment by CIBERSORT and further assessment, lower memory B cell and higher T cell regulatory were connected with better HPV (-) HNSCC outcome, higher activated memory CD4 T cell, higher T cell regulatory, and lower activated NK cell were linked with better HPV (+) result.
We finally got five forms of immune genes (CAMP, EDNRB, NTS, CXCL9, LHB) associated with HNSCC progression. Higher expressions of CAMP, EDNRB, and NTS were associated with increased overall survival in HPV (-) patients. Higher expression of CXCL9 and lower expression of LHB contributed to increased overall survival of HPV (+) patients.
There tend to be discrepancies in the cell structure of TIICs and immune-related genes in HPV (-) and HPV (+) HNSCC. These variances are typically too crucial for the therapeutic outcome of the patient and the development of the tumor. In specific, our sample established these candidate immune cells and immune-related genes as candidate reservoirs for further researches.
Multi-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage
The evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease.
We sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,483 African Americans, 1,477 Asians, and 960 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.
GWAS revealed 27 significant loci (p<5×10-8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/Band 3. GWAS of oxidative hemolysis identified variants in antioxidant enzymes including GLRX, GPX4, G6PD, and a novel golgi-transport protein SEC14L4.
Genome wide significant loci were also tested for association with the severity of steady state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1 and SEC14L4. Many of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases.
Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.
![stjosephs-hospital](https://www.stjosephs-hospital.com/cw/uploads/2021/10/6a6-300x294.jpeg)
stjosephs-hospital
Incorporating Genomic and Genetic Testing into the Treatment of Metastatic Luminal Breast Cancer
Background: Treatment of patients with luminal metastatic breast cancer (MBC) has become even more complex over the last few years as molecular profiling has begun to alter disease management. It is well accepted that MBC is not curable but is treatable. Today we are able to prolong progression-free survival and partly overall survival with targeted and more individual treatment strategies adjusted according to the molecular subtype.
Summary: Genetic and genomic testing has become therapeutically relevant in luminal MBC and is therefore an integral component within the treatment spectrum. By now, germline testing of BRCABRCAPIK3CA mutations are inevitable elements in disease management and the current state of the art in luminal MBC patients.
Furthermore, testing of ESR1 resistance mutation, ERBB2 mutation, microsatellite instability, and neurotrophic tyrosine receptor kinase (NTRK) gene fusion (mainly in secretory breast cancer) has recently gained increasing attention. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities. The following review summarizes current developments in genetic and genomic testing in luminal MBC.
Key messages: In luminal MBC genomics have become an integral component within the spectrum of oncological treatment establishing novel therapeutic facilities. Further developments in treatment personalization adjusted according to the molecular subtype should become increasingly important in order to enhance the progress of de-escalation of chemotherapy in luminal MBC. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities.
HIV-1 p24 recombinant antigen. |
MBS485187-01mg |
MyBiosource |
0.1mg |
EUR 300 |
HIV-1 p24 recombinant antigen. |
MBS485187-1mg |
MyBiosource |
1mg |
EUR 1300 |
HIV-1 p24 recombinant antigen. |
MBS485187-5x1mg |
MyBiosource |
5x1mg |
EUR 5795 |
HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations) |
0801002 |
Cusabio |
96T |
EUR 657.79 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
HIV-P24 antigen array kit |
VArk-Lsx001 |
Creative Biolabs |
unit |
Ask for price |
Description: Fourth-generation HIV immunoassays detect viral p24 protein in the blood. |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
abx257575-05mg |
Abbexa |
0.5 mg |
Ask for price |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
abx257575-100g |
Abbexa |
100 µg |
EUR 468.75 |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
abx257575-1mg |
Abbexa |
1 mg |
Ask for price |
Recombinant HIV-1 p24 Core Antigen |
HIV-277 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
HIV-1 p17-p24 recombinant antigen. |
00172-V |
Virogen |
1 MG |
EUR 850 |
HIV-1 p17-p24 recombinant antigen. |
00172-V-100ugvial |
Virogen |
100ug/vial |
EUR 150 |
|
Description: HIV-1 p17-p24 recombinant antigen. |
HIV-1 p17-p24 recombinant antigen. |
MBS485154-01mg |
MyBiosource |
0.1mg |
EUR 300 |
HIV-1 p17-p24 recombinant antigen. |
MBS485154-1mg |
MyBiosource |
1mg |
EUR 1300 |
HIV-1 p17-p24 recombinant antigen. |
MBS485154-5x1mg |
MyBiosource |
5x1mg |
EUR 5795 |
Antibody against HIV P24 antigen |
MBS478168-10mg |
MyBiosource |
10mg |
EUR 1560 |
Antibody against HIV P24 antigen |
MBS478168-1mg |
MyBiosource |
1mg |
EUR 275 |
Antibody against HIV P24 antigen |
MBS478168-20mg |
MyBiosource |
20mg |
EUR 2570 |
Antibody against HIV P24 antigen |
MBS478168-50mg |
MyBiosource |
50mg |
EUR 6185 |
Antibody against HIV P24 antigen |
MBS478168-5mg |
MyBiosource |
5mg |
EUR 840 |
Antibody against HIV P24 antigen |
MBS478169-10mg |
MyBiosource |
10mg |
EUR 1560 |
Antibody against HIV P24 antigen |
MBS478169-1mg |
MyBiosource |
1mg |
EUR 275 |
Antibody against HIV P24 antigen |
MBS478169-20mg |
MyBiosource |
20mg |
EUR 2570 |
Antibody against HIV P24 antigen |
MBS478169-50mg |
MyBiosource |
50mg |
EUR 6185 |
Antibody against HIV P24 antigen |
MBS478169-5mg |
MyBiosource |
5mg |
EUR 840 |
Antibody against HIV P24 antigen |
MBS478170-10mg |
MyBiosource |
10mg |
EUR 1560 |
Antibody against HIV P24 antigen |
MBS478170-1mg |
MyBiosource |
1mg |
EUR 275 |
Antibody against HIV P24 antigen |
MBS478170-20mg |
MyBiosource |
20mg |
EUR 2570 |
Antibody against HIV P24 antigen |
MBS478170-50mg |
MyBiosource |
50mg |
EUR 6185 |
Antibody against HIV P24 antigen |
MBS478170-5mg |
MyBiosource |
5mg |
EUR 840 |
Antibody against HIV P24 antigen |
MBS478171-10mg |
MyBiosource |
10mg |
EUR 1560 |
Antibody against HIV P24 antigen |
MBS478171-1mg |
MyBiosource |
1mg |
EUR 275 |
Antibody against HIV P24 antigen |
MBS478171-20mg |
MyBiosource |
20mg |
EUR 2570 |
Antibody against HIV P24 antigen |
MBS478171-50mg |
MyBiosource |
50mg |
EUR 6185 |
Antibody against HIV P24 antigen |
MBS478171-5mg |
MyBiosource |
5mg |
EUR 840 |
HIV-1 GAG P24 Recombinant Antigen |
00111-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
00111-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV 1 p24 core recombinant antigen. |
00177-V |
Virogen |
1 MG |
EUR 850 |
HIV 1 p24 core recombinant antigen |
00177-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen |
00177-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
00177-V-100ugvial |
Virogen |
100ug/vial |
EUR 150 |
|
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
MBS485109-01mg |
MyBiosource |
0.1mg |
EUR 300 |
HIV 1 p24 core recombinant antigen. |
MBS485109-1mg |
MyBiosource |
1mg |
EUR 1300 |
HIV 1 p24 core recombinant antigen. |
MBS485109-5x1mg |
MyBiosource |
5x1mg |
EUR 5795 |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
0801200 |
Zeptometrix |
5 X 96T |
EUR 2563 |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
801200 |
Zeptometrix |
5 X 96 Determinations |
EUR 2563 |
Recombinant HIV-1 p24 Antigen, His-tagged |
HIV-276 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
Recombinant HIV-1 p24 Antigen, His-tagged |
HIV-281 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations) |
0801008 |
Zeptometrix |
5 X 96T |
EUR 2505 |
Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit |
EH4101 |
FN Test |
96T |
EUR 571.5 |
|
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
MAB12321-100 |
The Native Antigen Company |
0.1 |
EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
MAB12321-500 |
The Native Antigen Company |
0.5 |
EUR 671.04 |
|
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Human Immunodeficiency Virus (HIV) p24 Antigen >95% |
MBS568670-1mg |
MyBiosource |
1mg |
EUR 2175 |
Human Immunodeficiency Virus (HIV) p24 Antigen >95% |
MBS568670-5x1mg |
MyBiosource |
5x1mg |
EUR 9585 |
Recombinant HIV-1 p24 Antigen, GST-tagged, HRP-Labled |
HIV-282 |
Creative BioMart |
1 vial |
EUR 798.4 |
Description: Protein |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614549-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3290 |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614549-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 295 |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614549-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1800 |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614549-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 450 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614545-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614545-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614545-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614545-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
NSL1389Hu |
Sunlong |
96 wells |
EUR 468 |
|
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614547-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3290 |
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614547-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 295 |
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614547-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1800 |
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614547-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 450 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2602892-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3040 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2602892-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 285 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2602892-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1670 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2602892-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 405 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
EIA06774h |
Enlibio |
each |
EUR 430 |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2610168-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2610168-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2610168-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2610168-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614543-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614543-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614543-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614543-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614550-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614550-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614550-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614550-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614544-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614544-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614544-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614544-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614548-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614548-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614548-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614548-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
Recombinant HIV-1 gag p17 and p24 Antigen, GST-tagged |
PT2-332 |
Creative BioMart |
1 vial |
EUR 798.4 |
Description: Protein |
Recombinant HIV-1 p24 gag Antigen, beta-galactosidase-tagged |
HIV-278 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
REC31743-100 |
The Native Antigen Company |
0.1 |
EUR 496.27 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
REC31743-500 |
The Native Antigen Company |
0.5 |
EUR 1363.78 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] |
REC31706-100 |
The Native Antigen Company |
0.1 |
EUR 457.08 |
|
Description: Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] |
REC31706-500 |
The Native Antigen Company |
0.5 |
EUR 1167.82 |
|
Description: Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
Bovine HIV-1 p24 core protein(HIV-1 p24) Anti-body ELISA Kit |
NSL1181Bo |
Sunlong |
96 T |
EUR 528 |
|
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614546-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614546-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614546-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
MBS2614546-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
HIV-1 p24 ELISA Kit |
Z7040001 |
Biochain |
1 kit |
EUR 865 |
HIV-1 p24 ELISA Kit |
MBS412756-5x960Tests |
MyBiosource |
5x960Tests |
EUR 17580 |
HIV-1 p24 ELISA Kit |
MBS412756-960Tests |
MyBiosource |
960Tests |
EUR 3770 |
HIV-1 p24 ELISA Kit |
MBS412756-96Tests |
MyBiosource |
96Tests |
EUR 510 |
Recombinant HIV-1 p24 Antigen, beta-galactosidase-tagged, Biotin-Labled |
HIV-280 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
Recombinant HIV-1 gag p17-p24 and gp41-gp120 Antigen |
VAC-0333 |
Creative BioMart |
0.5ml |
EUR 1598.4 |
|
Description: Protein |
OPEF01414-1MG - Recombinant Human Immunodeficiency Virus 1 (HIV 1-p24) Antigen |
OPEF01414-1MG |
Aviva Systems Biology |
1mg |
EUR 2216 |
|
Recombinant HIV-1 gag p17, p24 and gp120 Antigen, GST-tagged |
THP-0332 |
Creative BioMart |
1 vial |
EUR 2398.4 |
|
Description: Protein |
Human HIV (1+2) antigen&antibody ELISA Kit |
EK11777 |
SAB |
96Т |
EUR 799 |
|
Human HIV (1+2) antigen&antibody ELISA Kit |
AE62582HU-48Tests |
Abebio |
48 Tests |
EUR 360 |
|
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
AE62582HU-96Tests |
Abebio |
96 Tests |
EUR 680 |
|
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
AE62582HU-48T |
Abebio |
48T |
EUR 360 |
|
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
AE62582HU-96T |
Abebio |
96T |
EUR 680 |
|
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
MBS2800305-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6840 |
Human HIV (1+2) antigen&antibody ELISA Kit |
MBS2800305-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 480 |
Human HIV (1+2) antigen&antibody ELISA Kit |
MBS2800305-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3610 |
Human HIV (1+2) antigen&antibody ELISA Kit |
MBS2800305-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 805 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
MBS3802470-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
MBS3802470-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
MBS3802470-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
MBS3802470-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
00111-V |
Virogen |
1 MG |
EUR 850 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
00111-V-100ugvial |
Virogen |
100ug/vial |
EUR 150 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
MBS485158-01mg |
MyBiosource |
0.1mg |
EUR 300 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
MBS485158-1mg |
MyBiosource |
1mg |
EUR 1300 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
MBS485158-5x1mg |
MyBiosource |
5x1mg |
EUR 5795 |
Extended Range HIV-1 p24 ELISA Kit |
MBS412758-5x96Samples |
MyBiosource |
5x96Samples |
EUR 2575 |
Extended Range HIV-1 p24 ELISA Kit |
MBS412758-96Samples |
MyBiosource |
96Samples |
EUR 560 |
HIV-1 p24 (group O, strain BCF06) Antibody, Rabbit Pab, Antigen Affinity Purified |
MBS8119499-002mL |
MyBiosource |
0.02mL |
EUR 185 |
HIV-1 p24 (group O, strain BCF06) Antibody, Rabbit Pab, Antigen Affinity Purified |
MBS8119499-01mL |
MyBiosource |
0.1mL |
EUR 385 |
HIV-1 p24 (group O, strain BCF06) Antibody, Rabbit Pab, Antigen Affinity Purified |
MBS8119499-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
HIV-1 p17/24/gp120 antigen |
00169-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 p17/24/gp120 antigen |
00169-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
Recombinant HIV-1 p55 gag Antigen |
HIV-283 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
Recombinant HIV-1 p66 pol Antigen |
HIV-284 |
Creative BioMart |
1 vial |
EUR 798.4 |
|
Description: Protein |
HIV-1 intergase antigen |
00199-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
HIV-1 intergase antigen |
00199-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
HIV-1 (group M, subtype B, strain 92418) p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
MBS8105664-002mL |
MyBiosource |
0.02mL |
EUR 185 |
HIV-1 (group M, subtype B, strain 92418) p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
MBS8105664-01mL |
MyBiosource |
0.1mL |
EUR 385 |
HIV-1 (group M, subtype B, strain 92418) p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
MBS8105664-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
HIV-1 Recombinant antigen |
MBS320616-01mg |
MyBiosource |
0.1mg |
EUR 440 |
HIV-1 Recombinant antigen |
MBS320616-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1885 |
HIV-1 Recombinant antigen |
MBS320617-01mg |
MyBiosource |
0.1mg |
EUR 440 |
HIV-1 Recombinant antigen |
MBS320617-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1885 |
HIV-1 Recombinant antigen |
MBS320618-01mg |
MyBiosource |
0.1mg |
EUR 630 |
HIV-1 Recombinant antigen |
MBS320618-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2745 |
HIV-1 p24 Antibody |
20-abx137062 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
HIV-1 p24 Antibody |
abx023925-1mg |
Abbexa |
1 mg |
EUR 828 |
|
HIV-1 p24 Antibody |
abx023926-1mg |
Abbexa |
1 mg |
EUR 828 |
|
HIV-1 p24 Antibody |
abx021869-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
HIV-1 p24 Antibody |
abx021870-1mg |
Abbexa |
1 mg |
EUR 760.8 |
|
HIV-1 p24 Antibody |
abx021871-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
HIV-1 p24 Antibody |
abx021872-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
HIV-1 p24 Antibody |
abx021873-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
HIV-1 p24 Antibody |
abx021882-1mg |
Abbexa |
1 mg |
EUR 1178.4 |
|
HIV-1 p24 Antibody |
abx021883-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
HIV-1 p24 Antibody |
abx021886-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
HIV-1 p24 Antibody |
abx021887-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
HIV-1 p24 Antibody |
abx021888-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
HIV-1 p24 Antibody |
abx023027-1ml |
Abbexa |
1 ml |
EUR 693.6 |
|
HIV-1 p24 Antibody |
7313-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
HIV-1 p24 Antibody |
7313-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |